Abridge AI Vendor Risk Profile

Generative AI platform for clinical documentation that converts patient-clinician conversations into structured medical notes. Integrates with Epic and other EHRs, serving major health systems including Kaiser Permanente and Johns Hopkins.

Visit Abridge website

HQ: United States · Integrator

Risk overview

Risk score: 32/100

Risk tier: Moderate

Safety rating: 68/100 (higher is better)

Lower risk scores indicate lower assessed risk.

Last verified: Jan 15, 2026 (201 days ago) Stale — re-verification queued · 4 cited sources

Risk dimensions

DimensionRisk score
Data Handling45/100
IP Exposure16/100
Jurisdiction13/100
Security40/100
Regulatory Compliance50/100
Transparency40/100
Business Stability22/100
Dependency Chain28/100
Agent GovernanceNot assessed

Analyst summary

Rating: Acceptable

Abridge is the leading ambient AI medical scribe, deeply integrated with Epic and used by 150+ enterprise health systems. SOC 2 Type 1 and Type 2, HIPAA-compliant with BAA, and TX-RAMP listed. The compliance footprint is healthcare-appropriate; the main caveat is that Abridge is a heavily funded private company in a crowded scribe market still settling on winners.

Bottom line: Solid for Epic-anchored US health systems; verify HITRUST or ISO 27001 if your audit team requires those frameworks.

Strengths

Concerns

Best for

Avoid if

Citations

  1. Security Compliance — Soc2 Type2 (primary · medium confidence)
    https://trust.abridge.com/
    Verified 2026-01-15
  2. Vendors — Funding Stage (primary · medium confidence)
    https://www.abridge.com/blog/series-e
    Verified 2025-06-24
  3. Vendors — Valuation (primary · medium confidence)
    https://techcrunch.com/2025/06/24/in-just-4-months-ai-medical-scribe-abridge-doubles-valuation-to-5-3b/
    Verified 2025-06-24
  4. Data Handling — Hipaa Baa Available (primary · medium confidence)
    https://support.abridge.com/hc/en-us/articles/30235280178195-Abridge-HIPAA-Compliance
    Verified 2025-06-01